315 related articles for article (PubMed ID: 30563210)
21. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
[TBL] [Abstract][Full Text] [Related]
22. Perillyl alcohol as a radio-/chemosensitizer in malignant glioma.
Rajesh D; Stenzel RA; Howard SP
J Biol Chem; 2003 Sep; 278(38):35968-78. PubMed ID: 12805388
[TBL] [Abstract][Full Text] [Related]
23. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
24. A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.
Bailey HH; Wilding G; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Simon K; Marnocha R; Holstein SA; Stewart J; Lewis KA; Hohl RJ
Cancer Chemother Pharmacol; 2004 Oct; 54(4):368-76. PubMed ID: 15205914
[TBL] [Abstract][Full Text] [Related]
25. Intranasal administration of perillyl alcohol-loaded nanoemulsion and pharmacokinetic study of its metabolite perillic acid in plasma and brain of rats using ultra-performance liquid chromatography/tandem mass spectrometry.
da Silva Santos J; Diedrich C; Machado CS; da Fonseca CO; Khalil NM; Mainardes RM
Biomed Chromatogr; 2021 Apr; 35(4):e5037. PubMed ID: 33238042
[TBL] [Abstract][Full Text] [Related]
26. Development of a perillyl alcohol topical cream formulation.
Gupta A; Myrdal PB
Int J Pharm; 2004 Jan; 269(2):373-83. PubMed ID: 14706249
[TBL] [Abstract][Full Text] [Related]
27. Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation.
Afshordel S; Kern B; Clasohm J; König H; Priester M; Weissenberger J; Kögel D; Eckert GP
Pharmacol Res; 2015 Jan; 91():69-77. PubMed ID: 25497898
[TBL] [Abstract][Full Text] [Related]
28. The Rolipram-Perillyl Alcohol Conjugate (NEO214) Is A Mediator of Cell Death through the Death Receptor Pathway.
Cho HY; Thein TZ; Wang W; Swenson SD; Fayngor RA; Ou M; Marín-Ramos NI; Schönthal AH; Hofman FM; Chen TC
Mol Cancer Ther; 2019 Mar; 18(3):517-530. PubMed ID: 30647121
[TBL] [Abstract][Full Text] [Related]
29. Phase I trial of perillyl alcohol administered four times daily continuously.
Morgan-Meadows S; Dubey S; Gould M; Tutsch K; Marnocha R; Arzoomanin R; Alberti D; Binger K; Feierabend C; Volkman J; Ellingen S; Black S; Pomplun M; Wilding G; Bailey H
Cancer Chemother Pharmacol; 2003 Nov; 52(5):361-6. PubMed ID: 12904896
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
Drapeau A; Fortin D
Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
[TBL] [Abstract][Full Text] [Related]
31. Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response.
Yin P; Li H; Ke C; Cao G; Xin X; Hu J; Cai X; Li L; Liu X; Du B
Int J Nanomedicine; 2020; 15():1499-1515. PubMed ID: 32189965
[TBL] [Abstract][Full Text] [Related]
32. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
33. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin.
Yeruva L; Hall C; Elegbede JA; Carper SW
Anticancer Drugs; 2010 Jan; 21(1):1-9. PubMed ID: 19820395
[TBL] [Abstract][Full Text] [Related]
34. Temozolomide-Perillyl alcohol conjugate impairs Mitophagy flux by inducing lysosomal dysfunction in non-small cell lung Cancer cells and sensitizes them to irradiation.
Chang M; Song X; Geng X; Wang X; Wang W; Chen TC; Xie L; Song X
J Exp Clin Cancer Res; 2018 Oct; 37(1):250. PubMed ID: 30326943
[TBL] [Abstract][Full Text] [Related]
35. Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro.
Colombo M; Figueiró F; de Fraga Dias A; Teixeira HF; Battastini AMO; Koester LS
Int J Pharm; 2018 May; 543(1-2):214-223. PubMed ID: 29605695
[TBL] [Abstract][Full Text] [Related]
36. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
[TBL] [Abstract][Full Text] [Related]
37. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
Wang Z; Sun H; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
[TBL] [Abstract][Full Text] [Related]
38. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects.
Xu M; Floyd HS; Greth SM; Chang WC; Lohman K; Stoyanova R; Kucera GL; Kute TE; Willingham MC; Miller MS
Toxicol Appl Pharmacol; 2004 Mar; 195(2):232-46. PubMed ID: 14998688
[TBL] [Abstract][Full Text] [Related]
39. Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case.
Schönthal AH; Swenson S; Bonney PA; Wagle N; Simmon VF; Mathew AJ; Hurth KM; Chen TC
J Neurosurg Case Lessons; 2022 Aug; 4(8):. PubMed ID: 36088606
[TBL] [Abstract][Full Text] [Related]
40. Targeting integrins in malignant glioma.
Tabatabai G; Weller M; Nabors B; Picard M; Reardon D; Mikkelsen T; Ruegg C; Stupp R
Target Oncol; 2010 Sep; 5(3):175-81. PubMed ID: 20820929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
